Background and Purpose-Quality indicators serve as standards of care by which performance of individual hospitals is measured. Although several audits for monitoring quality of stroke care have been established in Europe, there is currently no consensus on quality indicators for acute stroke care or for methodology for collecting information on these measures. Methods-An up-to-date inventory on European stroke audits in place in 2006 was performed in the course of a project funded by the European Union (European Implementation Score Collaboration [EIS]). Two regional (Flanders, Belgium; Catalonia, Spain) and 4 national (Germany, Scotland, Sweden, England/Wales/Northern Ireland) stroke audits took part. Between November 2009 and July 2010, 2 standardized surveys and a series of interviews were performed to determine characteristics, methods, and content of these quality initiatives. For quality purposes, all summarized information was validated by representatives of the respective audits. Results-Overall, 123 quality indicators (91 process, 24 outcome, and 8 structural indicators) were identified.
A number of diagnostic, management, treatment, and secondary prevention strategies in clinical trial settings have been found to be effective in reducing morbidity and mortality after stroke. [1] [2] [3] [4] [5] For maximizing the benefit of the health of the entire population, these strategies have to be implemented efficiently in routine clinical care settings. 6 -8 A widely used tool for monitoring the implementation of treatment and prevention strategies in clinical routine is to evaluate quality of routine stroke care in different hospitals using standardized quality indicators that address different aspects of stroke care. 9 -12 Various quality registers and audits for monitoring and improving the quality of acute stroke care were established in the mid-nineties in Europe. [13] [14] [15] [16] A standardized comparison of the quality of acute stroke care in Europe would allow the identification of variations in implementation of effective strategies in different healthcare settings. This information might generate new hypotheses concerning which factors are successful in implementing research findings into clinical practice at different levels of the healthcare system. 6 Valid comparisons between European countries would further help to identify appropriate components of stroke services and to provide new insights into how best to configure and run stroke services. However, there is currently no European-wide consensus on content, data documentation, definition, and development process for quality indicators.
This article provides an overview on currently running European audits on acute stroke care, including characteristics such as initiation, funding, inclusion criteria, participating hospitals, data management, follow-ups, development and use of quality indicators, and reporting and benchmarking; the aim is to provide recommendations for the development of a European quality indicator set for acute stroke care.
Methods
An up-to-date inventory on stroke audits running in Europe was provided within the European Union Seventh Framework Programme (European Implementation Score Collaboration [EIS] , No. 223153). Quality registers and audits focusing on monitoring and improving the quality of acute stroke care on an institutional level were classified as audits. 17 National or regional audits were identified by review of the literature and personal communication that fulfilled the following criteria: running in 2006, focus on monitoring and improving the quality of acute stroke care, and data collection not based on hospital administrative data only. 13,24 -25 ) audits were identified that fulfilled the inclusion criteria. If no response to the request was received, then additional correspondence contacts were sought and contacted if available. If data supply was impossible within 6 months, the audit was not included in the overview.
A standardized questionnaire was developed documenting details on history and development of the registries and audits, patient characteristics, specification of data collection methodology, data management, and data quality. Details on the development and selection process of the used quality indicators, quality standards, benchmarking and reporting of results, and details on funding and participation were collected. Interviews with respective audit leads were undertaken to complement the information; official Web sites, public reports, and scientific publications were screened for relevant information. For quality purposes, all information was summarized in a written report that was validated by representatives of the respective audits for correctness. We developed standards for the future development and documentation of quality indicators in stroke care within European audits to allow for future comparisons within European countries. The study took place between November 2009 and July 2010.
Results

Characteristics of the Audits
The 6 national or regional audits included in this overview were established between 1994 and 2005 (Supplemental Table S1 ; http://stroke.ahajournals.org), with the first being Riks-Stroke in Sweden. Four of these (Flanders, Belgium; Germany; Scotland; Sweden) include continuous information on consecutive stroke patients, whereas 2 run only every 2 years, including a predefined number of consecutive patients per hospital (Catalonia, Spain; England/Wales/Northern Ireland); some include outpatients as well (Scotland, Sweden 
Benchmarking Between Hospitals
All audits provide a standardized comparison of the performance of an individual hospital against all hospitals (benchmarking). Hospitals' identities are blinded when benchmarked against in some audits (Flanders, Belgium; Catalonia, Spain; Germany); others present their results with complete (Scotland, Sweden) or partial (England/Wales/Northern Ireland) specification of the single hospitals in feedbacks and public reports. Feedback to the hospitals varies between once a month and once a year. In Catalonia, Spain, local meetings are held after each round to discuss results and areas for improvement (Supplemental Table S2 ).
Used Quality Indicators
Overall, 123 quality indicators were defined in the 6 audits (91 process, 24 outcome, and 8 structural indicators). The number of implemented quality indicators ranged from 10 (Scotland) to 12 (Flanders, Belgium), 27 indicators (Germany), 33 indicators (England/Wales/Northern Ireland), 41 indicators (Catalonia, Spain 2nd audit; Sweden) and 43 indicators (Catalonia, Spain 1st audit). Anticoagulants in patients with atrial fibrillation and brain imaging were the only quality indicators used in all, whereas 5 indicators (stroke unit care, swallowing test, antiplatelet/antithrombotic therapy at discharge, discharge on lipid-lowering therapy, thrombolytic therapy) were used in all but 1 audit. Early aspirin or antiplatelet therapy, assessment for rehabilitation, and discharge on blood-pressure-lowering therapy was used in 4 audits; 1 indicator was used in 3 audits, and 4 indicators were used in 2 audits. If quality indicators were used in a different manner, with different definitions and time periods, they were combined. Quality indicators used in at least 2 audits with respective definitions are summarized in Table 1 . Target values were used in Germany; Catalonia, Spain; and Scotland (Supplemental Table S3 ).
Development and Selection of Quality Indicators
In audits starting directly with a selection of indicators, (Supplemental Table S4 ) a structured approach of identifying potential indicators from guidelines was usually the starting point, followed by a review and rating process. The final selection was thereafter made by a multistakeholder/multi-professional panel or through the Delphi Method. [11] [12] [13] 19, 21 Methodology to develop quality indicators include, in Germany: a systematic literature review, an independent external evaluation, a prospective pilot study, a quality circle, involvement of users and interdisciplinary organizations, a semiannual update, and a steering committee. 11 A similar methodology, including internal consensus processes by multidisciplinary quality indicator boards, has been reported by Catalonia, Spain 13 ; England/Wales/Northern Ireland 21 ; and Scotland. 19 Riks-Stroke started in 1994 as the first national stroke registry worldwide with a limited number of indicators; it has subsequently been extended with the addition of new indicators and modifications of others by the steering committee. 14, 20 The identification of a core data set consisting of 13 key quality indicators was described by the Catalan Stroke Audit. 13 
Discussion
The 6 European national and regional audits on acute stroke care included in this overview vary widely in terms of inclusion criteria, participating hospitals, population coverage, data collection, documentation and verification, follow-up information and time points, outcome measures, and the development and selection process of quality indicators. Only 2 quality indicators were used in all, and another 13 of the identified 123 quality indicators were used in at least 2 of the audits.
The huge variation in the defined quality indicators might be because of substantial variations in the process of developing and endorsing quality indicators in different European countries. Variable methods from the available tools for quality indicator development were used by the European audits, such as expert opinion, a structured consensus process or a systematic selection, and rating process of available evidence. The development of the quality indicators did not involve in all countries a formal multidisciplinary group endorsed to oversee their development; also, the constitution of the multidisciplinary groups differed between countries. The audits also differed in the processes measured and have 
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Early mobilization ϩ ϩ been in operation and been updated differently. The variety in the quality indicators used might also be caused by the way data were collected, eg, the limited availability of variables when data were retrospectively extracted from medical records.
In the United States (US), there have been recent considerable efforts to develop common stroke quality indicators. A recent review identified 10 process-based quality indicators relevant to acute hospital-based care of ischemic stroke patients that have been developed and recommended by major stroke quality indicator organizations in the US. 10 One of these quality indicators (discharge on anticoagulation for patients with atrial fibrillation) was used in all 6 European stroke audits. ). Brain imaging that was used in all of the European audits and stroke unit care that was used in all of the European audits except for Catalonia, Spain where not included in the US data set. 10 The following 6 quality indicators used in at least 2 European audits were also not included in the US data set 10 : carotid/ vessel imaging (Flanders, Belgium; Germany; Sweden), discharge on blood-pressure-lowering medication (Scotland; Catalonia, Spain; Sweden; England/Wales/Northern Ireland), death during hospital stay (Germany, Sweden), ECG during hospitalization (Flanders, Belgium; Catalonia, Spain), assessment of mood disorders (Catalonia, Spain; England/Wales/ Northern Ireland), and early mobilization (Germany; Catalonia, Spain). A joint scientific statement from the American Heart Association and the American Stroke Association described the process of development of a set of evidencebased quality metrics. 26 These metrics are no established measures for direct comparison of quality of care between institutions, but these may lead to the adoption of formal quality indicators addressing all aspects of stroke care in comprehensive stroke centers. 26 Four of them are similar to quality indicators used in 1 or more of the European audits (early thrombolysis, thrombolysis within appropriate time window, early brain imaging, assessment of rehabilitation needs). 26 The agreement on a core quality indicator set with similar definitions and data collection methods might provide comparable data on quality of stroke care in Europe. Such an indicator set might be the first step in identifying successful methods to translate research findings into clinical practice across different domains of stroke care and different healthcare settings in Europe.
Based on an amalgamation of previous experiences, we suggest a set of quality criteria to develop prospectively a common European set of high standard quality indicators. These criteria include standards in the development, selection, and definition of quality indicators, a regular update of the developed indicators, verification of implementation by a pilot study, and the definition of documentation standards (Table 2) .
It may be feasible to implement the European quality indicator set in a stepwise approach, starting with the definition of a core data set to be collected in all countries and supplemental country-specific quality indicator sets. The development and use of common quality indicators should be based on standardized data collection of a common data set needed to operationalize the defined quality indicators in the exact same manner; this also should include variables for description of the population and further calculations as case mix adjustments, such as stroke severity, when using outcome measures as quality indicators. Standards for collecting comparable data should be defined and introduced across Europe. However, obtaining comparable data on stroke care in Europe is challenging because of substantial variations between healthcare systems with different treatment phases and sectors. 27 For example, the possibility of gaining follow-up information on stroke patients after hospital dis- 
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charge varies among the European healthcare systems, from requiring specific informed consent to availability of routine information on vital status. 28, 29 Equal to the results of the US initiative, the identified current stroke quality indicators are mostly limited to processes in the acute care of ischemic stroke patients in a hospital-based setting. 10 For assessing quality of care comprehensively, other aspects of stroke care, such as rehabilitation following acute care or long-term care after hospital discharge, should also be considered. 30 Except for death during hospital stay, outcome measures are scarce. Currently, most developed quality indicators are either general indicators for all stroke subtypes (eg, brain imaging or early rehabilitation) or focus mainly on ischemic strokes (eg, thrombolytic therapy). Indicators specifically focusing on the requirements of other pathological subtypes, such as intracerebral or subarachnoid hemorrhage, are currently lacking. 26 The current study has strengths and limitations. In contrast to previous overviews on quality indicators in Europe, 28 the coordinators of the respective audits have been contacted directly in the present overview. Thus, it was possible to take into account up-to-date and unpublished data, as well as to validate summarized information for completeness and correctness. However, only 7 audits were identified based on the defined criteria, and we cannot exclude that we have not identified all existing European stroke audits; in particular, additional stroke quality initiatives have been established later than 2006; those were not included in this overview.
Conclusions
To the best of our knowledge, this is the first comprehensive overview on currently used quality indicators in acute stroke care across ongoing European audits. This overview revealed a huge variety in measuring performance across European stroke audits. To compare quality of acute stroke care across Europe and to identify barriers and facilitators of implementation, a common set of European quality indicators has to be defined through a standardized and evidence-based procedure. Table S3 for list of quality targets, QI= quality indicators 
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